Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PolyPill for Prevention of Cardiovascular Disease in Middle-aged and Elderly Iranians
NCT01245608Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Oct 2011
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of aspirin + atorvastatin + hydrochlorothiazide + enalapril in cardiovascular disease (CVD), sponsored by Tehran University of Medical Sciences. Started Oct 2011; status: completed.
02
Drugs
aspirin + atorvastatin + hydrochlorothiazide + enalapril
03
Conditions
cardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT01245608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01245608.